Award
FSS #36F79727D006E
Interim Federal Supply Schedule Agreement with Replimune, Inc. for Hematology Products
Buyer
Department of Veterans Affairs
Award Amount
$25,000.00
Ceiling
$25,000.00
Awarded
November 01, 2026
Period of Performance
Nov 01, 2026 – Apr 30, 2027
Identifier
36F79727D006E
NAICS
325412
This award represents an interim agreement under a federal supply schedule contract, specifically Schedule 65 I B, which covers drugs, pharmaceuticals, and hematology-related products. The contract was awarded to Replimune, Inc., a biopharmaceutical company specializing in innovative therapies, reflecting their capability to supply specialized medical products. The procurement focuses on providing hematology and related pharmaceutical products, supporting the agency's healthcare and medical needs. This federal supply schedule contract signifies a streamlined procurement mechanism, allowing for efficient access to essential pharmaceuticals, which is crucial for timely and ongoing healthcare services. The scope includes supplying hematology-related products over a defined short-term period, with options for extension. The contract was awarded through the appropriate federal supply schedule vehicle, facilitating competitive and compliant sourcing; however, specific bidding details are not available. The performance period covers a multi-month timeframe within the next year, allowing for early delivery and potential further procurement under this schedule.
Description
INTERIM AGREEMENT UNDER FSS SCHEDULE 65 I B DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS